These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8922841)

  • 1. F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
    Blount CL; Dworkin HJ
    Clin Nucl Med; 1996 Nov; 21(11):831-3. PubMed ID: 8922841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinoma.
    Fridrich L; Messa C; Landoni C; Lucignani G; Moncayo R; Kendler D; Riccabona G; Fazio F
    Nucl Med Commun; 1997 Jan; 18(1):3-9. PubMed ID: 9061694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
    Wang H; Maurea S; Mainolfi C; Fiore F; Gravina A; Panico MR; Bazzicalupo L; Salvatore M
    Clin Nucl Med; 1997 Apr; 22(4):243-9. PubMed ID: 9099482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid.
    Balon HR; Fink-BennetT D; Stoffer SS
    J Nucl Med; 1992 Jul; 33(7):1393-5. PubMed ID: 1535374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
    Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
    Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
    Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
    J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of thyroid-stimulating hormone on 18F-fluorodeoxyglucose and 99mTc-methoxyisobutylisonitrile uptake in human poorly differentiated thyroid cancer cells in vitro.
    Kim CH; Yoo IeR; Chung YA; Park YH; Kim SH; Sohn HS; Chung SK
    Ann Nucl Med; 2009 Feb; 23(2):131-6. PubMed ID: 19225935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.
    Joensuu H; Ahonen A
    J Nucl Med; 1987 May; 28(5):910-4. PubMed ID: 3572549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
    Neumann DR; Esselstyn CB; Kim EY
    J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
    Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
    Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy.
    Bomanji JB; Gacinovic S; Gaze MN; Costa DC; Ell PJ
    Br J Radiol; 1998 Jan; 71(841):87-9. PubMed ID: 9534706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of [99mTC]MIBI and [18F]fluorodeoxyglucose for imaging recurrent medullary thyroid cancer and hyperparathyroidism in MEN 2a syndrome.
    Roelants V; Michel L; Lonneux M; Lacrosse M; Delgrange E; Donckier JE
    Acta Clin Belg; 2001; 56(6):373-7. PubMed ID: 11881324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
    Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
    J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma probe-guided resection and scanning with TC-99m MIBI of a local recurrence of follicular thyroid carcinoma.
    Boz A; Arici C; Güngör F; Yildiz A; Colak T; Karayalçin B
    Clin Nucl Med; 2001 Oct; 26(10):820-2. PubMed ID: 11564916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
    Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence.
    Curtet C; Carlier T; Mirallié E; Bodet-Milin C; Rousseau C; Barbet J; Kraeber-Bodéré F
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1556-62. PubMed ID: 17522858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental detection of a malignant hurthle cell carcinoma by Tc-99m sestamibi cardiac imaging.
    Fisher C; Vehec A; Kashlan B; Longa G; Houpt L; Howe K; Stark L; Cavanaugh D
    Clin Nucl Med; 2000 Jun; 25(6):469-70. PubMed ID: 10836698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.